Biopharma & Biotech Analyst Chen and Biotech Analyst Agrawal, along with KOLs Dr. Galimberti at University of Miami and Dr. Ehrlich, Medical Director at Dermatology & Laser Center, discuss key data readouts and debates in medical and aesthetic dermatology (relevant companies EOLS, RVNC, CUTR, RVLP, ROV, ARQT, RAPT, LLY, REGN, PFE, CNTB, JNJ) on an Analyst/Industry conference call to be held on August 16 at 1 pm. Webcast Link
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on EOLS:
- Evolus price target raised to $27 from $16 at H.C. Wainwright
- Evolus raises FY23 revenue view to $185M-$195M, consensus $189.0M
- Evolus reports Q2 EPS (32c), consensus (19c)
- EOLS Earnings this Week: How Will it Perform?
- Evolus raises FY23 revenue view to $185M-$195M from $180M-$190M
Questions or Comments about the article? Write to editor@tipranks.com